Eli Lilly and Company today announced groundbreaking results from a Phase 3 clinical trial for its investigational triple agonist, retatrutide,…
Read More

Eli Lilly and Company today announced groundbreaking results from a Phase 3 clinical trial for its investigational triple agonist, retatrutide,…
Read More
Researchers from the University of Michigan and the University of California San Diego have published a groundbreaking study identifying the…
Read More
The landscape of cancer treatment has been profoundly reshaped by immunotherapy, offering renewed hope and significantly improved prognoses for patients,…
Read More
The scientific understanding of creatine has undergone a significant transformation, moving from its traditional reputation as a niche bodybuilding aid…
Read More
In an era defined by the dual crises of mounting environmental degradation and an urgent need for sustainable energy, a…
Read More
The landscape of type 2 diabetes management and cardiovascular risk reduction in the United States has been significantly reshaped with…
Read More
For over a century, Science News has stood as a beacon of independent, nonprofit journalism, dedicated to delivering accurate and…
Read More
The landscape of data engineering and analytics has evolved dramatically, moving from ad-hoc querying to complex, mission-critical data pipelines that…
Read More
Scientists have uncovered evidence that evolution has relied on the same genetic "cheat sheet" for more than 120 million years,…
Read More
Pharmaceutical R&D stands at a pivotal inflection point, witnessing a profound transformation in how diseases are targeted and treated. The…
Read More